FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 126 filers reported holding FATE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $10,879,000 | +1019.2% | 125,350 | +962.7% | 1.35% | +977.6% |
| Q1 2021 | $972,000 | +196.3% | 11,795 | -20.2% | 0.12% | +15.7% |
| Q1 2020 | $328,000 | -83.1% | 14,780 | -88.2% | 0.11% | -82.9% |
| Q3 2019 | $1,942,000 | +55.2% | 125,060 | +103.0% | 0.63% | +55.5% |
| Q2 2019 | $1,251,000 | -60.2% | 61,615 | -65.5% | 0.41% | -63.4% |
| Q1 2019 | $3,141,000 | +71.5% | 178,790 | +25.2% | 1.11% | +50.4% |
| Q4 2018 | $1,832,000 | – | 142,760 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |